Boehringer Ingelheim acquires T3 Pharma for $509m
Pharmaceutical Technology
NOVEMBER 23, 2023
T3 Pharma uses a bacterial secretion system for the delivery of immune-modulating proteins to cancer cells and tumour micro-environments.
Thu.Nov 23, 2023
242 
Genentech and NVIDIA enter into strategic AI research collaboration
Pharma Times
NOVEMBER 23, 2023
Both companies will use their platforms to accelerate drug discovery and development - News - PharmaTimes
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
EirGenix and Sandoz win EU approval for Herceptin biosimilar
Pharmaceutical Technology
NOVEMBER 23, 2023
EirGenix and Sandoz's biosimilar has been approved for all the indications as the reference biologic, Roche’s Herceptin.
Worst Food Safety Scandals of 2023
XTalks
NOVEMBER 23, 2023
Despite technological advancements in food safety in recent years, 2023 has been marked by some alarming food safety scandals globally, impacting public health and trust in the food industry. Here, we uncover some of the worst food safety scandals of 2023, shedding light on the causes and consequences of these outbreaks and recalls. 1. Salmonella Outbreak from Poultry — The US A widespread Salmonella outbreak linked to contaminated poultry affected thousands across multiple states this year.
SK bioscience and Hilleman to develop Ebola-Zaire virus vaccine
Pharmaceutical Technology
NOVEMBER 23, 2023
SK bioscience has signed an agreement with Hilleman Laboratories Singapore for the co-development of a vaccine against the Zaire Ebola virus.
Moderna completes next stage of UK R&D facility build
pharmaphorum
NOVEMBER 23, 2023
US biotech Moderna has completed the installation of its clinical laboratories at its new R&D facility in the UK dedicated to the discovery of new mRNA vaccines and therapeutics, part of a 10-year partnership with the government agreed last year that has been estimated to be worth around £1 billion.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Wheel Unveils Enhanced Virtual Care Platform with New Telehealth Solutions
XTalks
NOVEMBER 23, 2023
Wheel, a prominent virtual care platform dedicated to enabling companies to provide consumer-centric care, has unveiled the latest iteration of its virtual care platform. This advancement is geared towards assisting enterprise organizations in establishing integrated care experiences. Wheel’s new platform offers customizable care programs for customers, complemented by a comprehensive network of clinicians spanning the nation.
China’s NMPA accepts NDA for AnHeart and Innovent’s lung cancer therapy
Pharmaceutical Technology
NOVEMBER 23, 2023
China’s NMPA has accepted NDA for AnHeart Therapeutics taletrectinib to treat locally advanced or metastatic ROS1-positive NSCLC.
Biotech startup Cradle raises $24 million Series A to accelerate AI technology
BioPharma Reporter
NOVEMBER 23, 2023
Cradle, the biotech startup using generative AI to help scientists design and engineer proteins, has raised $24 million in Series A funding.
The benefits of using an app to manage gestational diabetes: Niki’s story
Pharmaceutical Technology
NOVEMBER 23, 2023
When expectant mothers are diagnosed with gestational diabetes mellitus (GDM) they often feel anxious and need extra support.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Flywheel and Microsoft collaborate to unlock powerful data insights in medical imaging
Outsourcing Pharma
NOVEMBER 23, 2023
Healthcare breakthroughs have long-standing barriers when it comes to unlocking the powerful insights trapped in medical imaging data.
Simcere and Connect sign licensing agreement for anti IL-4R? AD drug
Pharmaceutical Technology
NOVEMBER 23, 2023
Simcere will have the rights to develop and commercialise rademikibart in mainland China, Macau, Taiwan, and Hong Kong.
AstraZeneca joins KRAS push in cancer with Chinese deal
pharmaphorum
NOVEMBER 23, 2023
AstraZeneca joins KRAS push in cancer with Chinese deal Phil.
Syncona to acquire biotechnology company Freeline Therapeutics
Pharmaceutical Technology
NOVEMBER 23, 2023
Syncona has signed a definitive agreement to acquire clinical-stage biotechnology company Freeline Therapeutics
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
The power of data science platforms to cut through the complexity of modern-day clinical research
pharmaphorum
NOVEMBER 23, 2023
The power of data science platforms to cut through the complexity of modern-day clinical research Mike.
Vivodyne raises funding for lab-grown human organs
Pharmaceutical Technology
NOVEMBER 23, 2023
Biotech company Vivodyne has raised $38m in total seed financing for the development of lab-grown human organs.
How can the value of patient engagement be quantified and measured?
pharmaphorum
NOVEMBER 23, 2023
How can the value of patient engagement be quantified and measured? Mike.
Adragos Pharma's Japanese site is 'sweet spot' among acquisitions
Outsourcing Pharma
NOVEMBER 23, 2023
German CDMO Adragos Pharma has its eye on expansion and is continually branching out into new markets.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
How birth tissue donations are fuelling the cell therapy revolution
pharmaphorum
NOVEMBER 23, 2023
How birth tissue donations are fuelling the cell therapy revolution Mike.
Novo Nordisk to affirm superiority of CagriSema in obesity market
BioPharma Reporter
NOVEMBER 23, 2023
Eli Lilly recently received FDA approval for Zepbound, a GLP-1 weekly injectable drug to treat obesity.
UK “keeping up momentum” on clinical trials review
pharmaphorum
NOVEMBER 23, 2023
Lord James O’Shaughnessy has welcomed the UK government’s official response to his review of commercial clinical trials, saying there have been a number of positive developments since it was published in the spring.
Supercharging AI-drug discovery with strategic multiomic biobanks
Drug Discovery World
NOVEMBER 23, 2023
Niven R. Narain , PhD, President and CEO of BPGbio asks how a better calibre of biobanks in life sciences can lead to more drugs making it to market. Artificial Intelligence (AI) has become a popular buzzword in the drug discovery and development lexicon but not all approaches to AI-driven drug discovery produce meaningful insights that translate into real compounds which ultimately demonstrate clinical efficacy in human trials.
Roles and Responsibilities of Specialized Clinical Supply Experts
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Exploring the impact of patient flow forecasting on the patient and the HCP
pharmaphorum
NOVEMBER 23, 2023
Exploring the impact of patient flow forecasting on the patient and the HCP Mike.
Drug discovery trends: From regulation to embracing AI
Drug Discovery World
NOVEMBER 23, 2023
This is the latest episode of the free DDW narrated podcast, “Drug discovery trends: From regulation to embracing AI”, which covers two articles written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: From the Editor: Law and order and How AI in pharma can live up to the hype. In the first article, DDW Editor Reece Armstrong comments on the post-Covid industry landscape.
Supercharge your supply chain: Harnessing AI to gain competitive advantage
pharmaphorum
NOVEMBER 23, 2023
Supercharge your supply chain: Harnessing AI to gain competitive advantage Mike.
New podcast on drug discovery trends
Drug Discovery World
NOVEMBER 23, 2023
This is the latest episode of the free DDW narrated podcast, “Drug discovery trends: From regulation to embracing AI”, which covers two articles written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: From the Editor: Law and order and How AI in pharma can live up to the hype. In the first article, DDW Editor Reece Armstrong comments on the post-Covid industry landscape.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Novo Nordisk will invest €2.1bn in French manufacturing site
pharmaphorum
NOVEMBER 23, 2023
Novo Nordisk will invest €2.1bn in French manufacturing site Phil.
What Makes the Air Up Watter Bottle So Unique? + FTC Cracks Down on Food Industry Influencers – Xtalks Food Podcast Ep. 137
XTalks
NOVEMBER 23, 2023
Air Up, a revolutionary water bottle company, emerged from a unique academic project and rapidly transformed the way we perceive and consume water. In this episode of the Xtalks Food Podcast, Sydney talks about the Munich-based startup, which began as a university project in 2016, combining neuroscience and design. It’s the first hydration system that flavors water solely through scent.
Next steps for the CALYX trial for cerebral Adrenoleukodystrophy
Drug Discovery World
NOVEMBER 23, 2023
Minoryx has announced enrollment of first patients with cerebral Adrenoleukodystrophy (cALD) in the US Phase III clinical trial, CALYX. As part of CALYX, Minoryx is conducting an extensive pre-screening MRI-based campaign aimed at identifying eligible adult X-linked Adrenoleukodystrophy (X-ALD) patients with cALD. In June 2023, the US Food and Drug Administration (FDA) approved CALYX’s trial of leriglitazone to treat adult male X-ALD patients with cALD.
Oncology KRAS-targeting therapy market to exceed $4 billion by 2029
BioPharma Reporter
NOVEMBER 23, 2023
Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations are common in solid tumors, including lung cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.
Accelerating Clinical Supply Through Integrated Drug Development
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Let's personalize your content